Your browser doesn't support javascript.
loading
Response assessment of post-treatment head and neck cancers to determine further management using NI-RADS (Neck Imaging Reporting and Data System): a subgroup analysis of a randomized controlled trial.
Mahajan, Abhishek; Unde, Himangi; Sable, Nilesh P; Shukla, Shreya; Vaish, Richa; Patil, Vijay; Agarwal, Ujjwal; Agrawal, Archi; Noronha, Vanita; Joshi, Amit; Kapoor, Akhil; Menon, Nandini; Agarwal, Jai Prakash; Laskar, Sarbani Ghosh; Dcruz, Anil Keith; Chaturvedi, Pankaj; Pai, Prathamesh; Rane, Swapnil Ulhas; Bal, Munita; Patil, Asawari; Prabhash, Kumar.
Afiliação
  • Mahajan A; Department of Radiodiagnosis, The Clatterbridge Cancer Centre, University of Liverpool, Liverpool, United Kingdom.
  • Unde H; Department of Radiodiagnosis and Imaging, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Sable NP; Department of Radiodiagnosis and Imaging, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Shukla S; Department of Radiodiagnosis and Imaging, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Vaish R; Department of Radiodiagnosis and Imaging, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Patil V; Department of Head and Neck Surgery, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Agarwal U; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Agrawal A; Department of Radiodiagnosis and Imaging, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Noronha V; Department of Nuclear Medicine, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Kapoor A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Menon N; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Agarwal JP; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Laskar SG; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Dcruz AK; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Chaturvedi P; Department of Head and Neck Surgery, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Pai P; Department of Head and Neck Surgery, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Rane SU; Department of Head and Neck Surgery, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Bal M; Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Patil A; Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
  • Prabhash K; Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Front Oncol ; 13: 1200366, 2023.
Article em En | MEDLINE | ID: mdl-37810970
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido